Halia Therapeutics works to develop medicines to treat diseases driven by chronic inflammation and neurodegeneration, according to a Jan. 19 news release from the company.
Prior to her new role, Dr. Janát-Amsbury served as an executive medical director of early oncology development and a project team lead at Amgen, a biopharmaceutical company based in Thousand Oaks, Calif.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.